Cosmo Pharmaceuticals announces a change in its board of directors
Cosmo Pharmaceuticals N.V. / Key word(s): Miscellaneous
10-May-2021 / 06:00 GMT/BST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.
* retirement of Dr. Hans Christoph Tanner as non-executive director
* proposal for the appointment of Mr. David Maris as new non-executive board member
Dublin, Ireland - 10 May 2021: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) today announced the resignation, due to his retirement, of Dr. Hans Christoph Tanner as a non-executive board member and the proposal for the appointment of Mr. David Maris as a new non-executive board member, both to take effect from the next AGM on the 28th of May.